|
KingNastidon posted:People aren't letting The Miracle Cancer/Alzheimer's Cure die on the vine in the clinic because treating the disease is more profitable than curing it, maaaann. Glybera was a cure for a rare form of pancreatitis. The company charged $1 million for the cure, sold it once, and now it is off the market entirely. Their reasoning for pricing it that high was because treatments for similar rare diseases normally cost $300,000 / year for the rest of the patient's life. The research was publicly funded by the University of British Columbia.
|
#
¿
Aug 8, 2020 07:13
|
|
|
|
| # ¿ May 11, 2024 21:29 |
|